-
公开(公告)号:US08729266B2
公开(公告)日:2014-05-20
申请号:US12668900
申请日:2008-06-16
申请人: Christopher W. Grote , Brian Orr , Tao Jiang , Gary L. Cantrell
发明人: Christopher W. Grote , Brian Orr , Tao Jiang , Gary L. Cantrell
IPC分类号: C07D489/02
CPC分类号: C07D489/02 , C07D489/08
摘要: The present invention is directed to the reduction of an N-imine moiety or a hemiaminal moiety of a morphinan in the presence of a ruthenium, rhodium, or iridium asymmetric catalyst and a hydrogen source.
摘要翻译: 本发明涉及在钌,铑或铱不对称催化剂和氢源的存在下还原吗啡喃的N-亚胺部分或半缩醛部分。
-
公开(公告)号:US20100197921A1
公开(公告)日:2010-08-05
申请号:US12668900
申请日:2008-06-16
申请人: Christopher W. Grote , Brian Orr , Tao Jiang , Gary L. Cantrell
发明人: Christopher W. Grote , Brian Orr , Tao Jiang , Gary L. Cantrell
IPC分类号: C07D489/00 , C07D489/08 , C07D489/02
CPC分类号: C07D489/02 , C07D489/08
摘要: The present invention is directed to the reduction of an N-imine moiety or a hemiaminal moiety of a morphinan in the presence of a ruthenium, rhodium, or iridium asymmetric catalyst and a hydrogen source.
摘要翻译: 本发明涉及在钌,铑或铱不对称催化剂和氢源的存在下还原吗啡喃的N-亚胺部分或半缩醛部分。
-
3.
公开(公告)号:US20100113788A1
公开(公告)日:2010-05-06
申请号:US12630171
申请日:2009-12-03
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/02
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the preparation of 6-keto morphinans.
摘要翻译: 本发明涉及6-酮吗啡喃的制备。
-
公开(公告)号:US08148528B2
公开(公告)日:2012-04-03
申请号:US12469951
申请日:2009-05-21
申请人: Peter X. Wang , Frank W. Moser , Gary L. Cantrell , Tao Jiang , Robert E. Halvachs , Christopher W. Grote
发明人: Peter X. Wang , Frank W. Moser , Gary L. Cantrell , Tao Jiang , Robert E. Halvachs , Christopher W. Grote
IPC分类号: C07D489/08
CPC分类号: C07D489/02 , C07D221/28 , C07D489/08
摘要: The invention generally provides processes and intermediate compounds useful for the production of normorphinans and derivatives of normorphinans.
摘要翻译: 本发明通常提供可用于生产正丝菌素和正大脑啡肽衍生物的方法和中间体化合物。
-
公开(公告)号:US20090299069A1
公开(公告)日:2009-12-03
申请号:US12469951
申请日:2009-05-21
申请人: Peter X. Wang , Frank W. Moser , Gary L. Cantrell , Tao Jiang , Robert E. Halvachs , Christopher W. Grote
发明人: Peter X. Wang , Frank W. Moser , Gary L. Cantrell , Tao Jiang , Robert E. Halvachs , Christopher W. Grote
IPC分类号: C07D489/08
CPC分类号: C07D489/02 , C07D221/28 , C07D489/08
摘要: The invention generally provides processes and intermediate compounds useful for the production of normorphinans and derivatives of normorphinans.
摘要翻译: 本发明通常提供可用于生产正丝菌素和正大脑啡肽衍生物的方法和中间体化合物。
-
6.
公开(公告)号:US20100081818A1
公开(公告)日:2010-04-01
申请号:US12630192
申请日:2009-12-03
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/00
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the preparation of 6-hydroxy morphinans having formula (II) or N-alkylated 6-hydroxy morphinans having formula (III).
摘要翻译: 本发明涉及具有式(II)的6-羟基吗啡烷或具有式(III)的N-烷基化的6-羟基吗啡喃的制备。
-
7.
公开(公告)号:US08273888B2
公开(公告)日:2012-09-25
申请号:US12630171
申请日:2009-12-03
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/02 , C07D489/08
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the preparation of 6-keto morphinans.
摘要翻译: 本发明涉及6-酮吗啡喃的制备。
-
8.
公开(公告)号:US20100041888A1
公开(公告)日:2010-02-18
申请号:US12444421
申请日:2008-05-02
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/02
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the conversion of a 6-keto morphinan to a 6-alpha-hydroxy morphinan in the presence of a ruthenium, rhodium, or iridium asymmetric catalyst and a hydrogen source.
摘要翻译: 本发明涉及在钌,铑或铱不对称催化剂和氢源的存在下将6-酮基吗啡喃转化为6-α-羟基吗啡喃。
-
9.
公开(公告)号:US08524904B2
公开(公告)日:2013-09-03
申请号:US12630192
申请日:2009-12-03
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/08 , C07D489/02
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the preparation of 6-hydroxy morphinans having formula (II) or N-alkylated 6-hydroxy morphinans having formula (III).
摘要翻译: 本发明涉及具有式(II)的6-羟基吗啡烷或具有式(III)的N-烷基化的6-羟基吗啡喃的制备。
-
10.
公开(公告)号:US07985858B2
公开(公告)日:2011-07-26
申请号:US12444421
申请日:2008-05-02
申请人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
发明人: Christopher W. Grote , Peter X. Wang , Tao Jiang , Gary L. Cantrell , Frank W. Moser , Catherine E. Thomasson
IPC分类号: C07D489/08 , C07D489/02
CPC分类号: C07D489/02 , Y02P20/55
摘要: The present invention is directed to the conversion of a 6-keto morphinan to a 6-alpha-hydroxy morphinan in the presence of a ruthenium, rhodium, or iridium asymmetric catalyst and a hydrogen source.
摘要翻译: 本发明涉及在钌,铑或铱不对称催化剂和氢源的存在下将6-酮基吗啡喃转化为6-α-羟基吗啡喃。
-
-
-
-
-
-
-
-
-